EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy

Silvia Cipriani, Marta Guerrero-Valero, Stefano Tozza iD, Edward Zhao, Veith Vollmer, Danique Beijer, Matt Danzi, Cristina Rivellini, Dejan Lazarevic, Giovanni Battista Pipitone, Bianca Rose Grosz iD, Costanza Lamperti and 12 more

European Journal of Neurology · 2023-02 · 30 (2) · 511-526

DOI: 10.1111/ene.15601 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2022-11-21. Written by Silvia Cipriani and 23 co-authors. Institution: Division of Neuroscience, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Milan, Italy. Major MEDLINE topics: Charcot-Marie-Tooth Disease, Myosins. Cited 10 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Telethon, Ministero della Salute, Regione Lombardia.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and purpose Charcot–Marie–Tooth disease (CMT) is a heterogeneous group of disorders caused by mutations in at least 100 genes. However, approximately 60% of cases with axonal neuropathies (CMT2) still remain without a genetic diagnosis. We aimed at identifying novel disease genes responsible for CMT2.

Methods

We performed whole exome sequencing and targeted next generation sequencing panel analyses on a cohort of CMT2 families with evidence for autosomal recessive inheritance. We also performed functional studies to explore the pathogenetic role of selected variants.

Results

We identified rare, recessive variants in the MYO9B (myosin IX) gene in two families with CMT2. MYO9B has not yet been associated with a human disease. MYO9B is an unconventional single‐headed processive myosin motor protein with signaling properties, and, consistent with this, our results indicate that a variant occurring in the MYO9B motor domain impairs protein expression level and motor activity. Interestingly, a Myo9b ‐null mouse has degenerating axons in sciatic nerves and optic nerves, indicating that MYO9B plays an essential role in both peripheral nervous system and central nervous system axons, respectively. The degeneration observed in the optic nerve prompted us to screen for MYO9B mutations in a cohort of patients with optic atrophy (OA). Consistent with this, we found compound heterozygous variants in one case with isolated OA.

Conclusions

Novel or very rare variants in MYO9B are associated with CMT2 and isolated OA.

Subjects

MeSH terms (MEDLINE)

Charcot-Marie-Tooth DiseaseMyosinsAnimalsHumansMiceMutationPedigreePhenotypeProteinsSciatic Nerve

Author keywords

Charcot-Marie-Tooth neuropathyaxonal neuropathymutationsmyosin

Substances

Proteinsmyosin IXBMyosins

Authors and institutions

  • Division of Neuroscience, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Institute of Integrative Cell Biology and Physiology, Westfalian Wilhelms University Münster, Münster, Germany.
  • Department of Human Genetics and Hussman Institute for Human Genomics, University of Miami, Miami, Florida, USA.

ORCID profiles: Stefano Tozza, Bianca Rose Grosz, Chiara Pisciotta, Davide Pareyson, Stefano C Previtali, Fiore Manganelli, Alessandra Bolino

Funding

  • Telethon
  • Ministero della Salute
  • Regione Lombardia

Cite

APA

Cipriani, S., Guerrero-Valero, M., Tozza, S., Zhao, E., Vollmer, V., Beijer, D., Danzi, M., Rivellini, C., Lazarevic, D., Pipitone, G. B., Grosz, B. R., Lamperti, C., Marzoli, S. B., Carrera, P., Devoto, M., Pisciotta, C., Pareyson, D., Kennerson, M., Previtali, S. C., …, & Bolino, A. (2023). Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy. European Journal of Neurology, 30(2), 511-526. https://doi.org/10.1111/ene.15601

Vancouver

Cipriani S, Guerrero-Valero M, Tozza S, Zhao E, Vollmer V, Beijer D, et al. Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy. European Journal of Neurology. 2023;30(2):511-526. doi:10.1111/ene.15601

BibTeX
@article{Cipriani2023,
  author = {Cipriani, Silvia and Guerrero-Valero, Marta and Tozza, Stefano and Zhao, Edward and Vollmer, Veith and Beijer, Danique and Danzi, Matt and Rivellini, Cristina and Lazarevic, Dejan and Pipitone, Giovanni Battista and Grosz, Bianca Rose and Lamperti, Costanza and Marzoli, Stefania Bianchi and Carrera, Paola and Devoto, Marcella and Pisciotta, Chiara and Pareyson, Davide and Kennerson, Marina and Previtali, Stefano C and Zuchner, Stephan and Scherer, Steven S and Manganelli, Fiore and Bähler, Martin and Bolino, Alessandra},
  title = {Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {2},
  pages = {511--526},
  doi = {10.1111/ene.15601}
}
Start for free →